Sugi Predict

Sugi Predict / Targets / PNN

PNN

Pinin · Q9H307 · PNN on Sugi Atlas →

0 patent compounds predicted against PNN, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PNN by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia PHASE4COMPLETED
The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy PHASE3UNKNOWN
TRPM8 Activators for Peripheral Neuropathy PHASE2ACTIVE_NOT_RECRUITING
ACD440 Gel in Peripheral Neuropathic Pain PHASE2COMPLETED
Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis PHASE1/PHASE2UNKNOWN
Oral LAT8881 in Neuropathic Pain PHASE2COMPLETED
Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy PHASE2RECRUITING
Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy PHASE1COMPLETED
The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture nanRECRUITING
Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction nanCOMPLETED
Treatment for Painful Diabetic Neuropathy nanCOMPLETED
Dorsal Root Ganglion Stimulation in Postherpetic Neuropathy nanCOMPLETED
A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence nanCOMPLETED
Additional Effects of Sensory Integration Along With Focused Regimen Exercises on Kinaesthesia & Proprioception in Diabetic Peripheral Neuropathy. nanCOMPLETED
Diagnostic of Chemotherapy Induced Neuropathy in Children nanCOMPLETED
Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain nanCOMPLETED
Identification of Chemotherapy-induced Peripheral Neuropathy nanCOMPLETED
Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy nanCOMPLETED
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) nanRECRUITING
Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction nanRECRUITING
Impact of Diabetic Polyneuropathy on Carpal Tunnel Syndrome: Shear Wave Elastography, Ultrasound, and Hand Function nanCOMPLETED
Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia nanNOT_YET_RECRUITING
Exercises for Patients Who Were Receiving Chemotherapy nanCOMPLETED
Perineural Platelet-rich Plasma for Diabetic Neuropathy Pain nanCOMPLETED
Central Sensitization in Painful and Painless Diabetic Peripheral Neuropathy nanNOT_YET_RECRUITING
Diagnostic Markers of Neuropathic Odontalgia nanUNKNOWN
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy nanRECRUITING
Coeliac Plexus Neurolysis Versus Splanchnic Nerve Neurolysis nanUNKNOWN
Pistachio Intake, Satiety and Body Weight Control in Healthy Adult Women nanUNKNOWN
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a PNN binder may also engage these)

ProteinNameSimilarity
Q5R5X0 — 1.000 Q5R5X0 →
O35691 — 1.000 O35691 →
P79149 — 1.000 P79149 →
P79122 — 0.996 P79122 →
Q8N3X1 — 0.987 Q8N3X1 →
O94913 — 0.987 O94913 →
Q15424 — 0.985 Q15424 →
Q568R1 — 0.985 Q568R1 →
Q6ZU65 — 0.985 Q6ZU65 →
Q9WU62 — 0.984 Q9WU62 →
Q76FK4 — 0.984 Q76FK4 →
Q4KLH6 — 0.984 Q4KLH6 →
Q80WC1 — 0.984 Q80WC1 →
Q14151 — 0.984 Q14151 →
Q5XIN3 — 0.984 Q5XIN3 →
Q5VUA4 — 0.983 Q5VUA4 →
Q80YR5 — 0.983 Q80YR5 →
Q99PP2 — 0.983 Q99PP2 →
Q640U0 — 0.983 Q640U0 →
Q8N4S0 — 0.983 Q8N4S0 →
Q5TYQ8 — 0.983 Q5TYQ8 →
Q5REG6 — 0.983 Q5REG6 →
Q9H0G5 — 0.983 Q9H0G5 →
Q5SZT7 — 0.983 Q5SZT7 →
THRAP3 Thyroid hormone receptor-associated protein 3 0.982 landscape →
A6QLA6 — 0.982 A6QLA6 →
Q6ZQ06 — 0.982 Q6ZQ06 →
Q6PCQ0 — 0.982 Q6PCQ0 →
Q8TDR0 — 0.982 Q8TDR0 →
Q5XHJ5 — 0.982 Q5XHJ5 →